Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1971 1
1972 3
1973 3
1974 1
1975 1
1977 2
1978 2
1979 2
1980 2
1982 3
1983 1
1984 1
1985 4
1986 1
1987 3
1988 15
1989 13
1990 5
1991 8
1992 6
1993 6
1994 16
1995 13
1996 7
1997 21
1998 9
1999 17
2000 14
2001 12
2002 10
2003 18
2004 13
2005 23
2006 13
2007 13
2008 18
2009 17
2010 13
2011 15
2012 22
2013 32
2014 23
2015 22
2016 36
2017 42
2018 50
2019 48
2020 60
2021 69
2022 50
2023 67
2024 80
2025 88
2026 16

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

961 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy of micronized purified flavonoid fraction (Daflon ) on improving individual symptoms, signs and quality of life in patients with chronic venous disease: a systematic review and meta-analysis of randomized double-blind placebo-controlled trials.
Kakkos SK, Nicolaides AN. Kakkos SK, et al. Int Angiol. 2018 Apr;37(2):143-154. doi: 10.23736/S0392-9590.18.03975-5. Epub 2018 Jan 31. Int Angiol. 2018. PMID: 29385792 Free article.
The aim of this systematic review and meta-analysis was to study the effectiveness of the micronized purified flavonoid fraction (MPFF, Daflon ) across the spectrum of defined venous symptoms, signs, quality of life (QoL) and treatment assessment by the physician. ...
The aim of this systematic review and meta-analysis was to study the effectiveness of the micronized purified flavonoid fraction (MPFF, D …
Three treatments for chronic venous insufficiency: escin, hydroxyethylrutoside, and Daflon.
Frick RW. Frick RW. Angiology. 2000 Mar;51(3):197-205. doi: 10.1177/000331970005100303. Angiology. 2000. PMID: 10744007 Review.
Escin, hydroxyethylrutoside (HR), and Daflon have been shown to be safe and effective for the treatment of chronic venous insufficiency (CVI). ...Additional independent effects that would be useful for the treatment of CVI are that they reduce permeability and fragility; H …
Escin, hydroxyethylrutoside (HR), and Daflon have been shown to be safe and effective for the treatment of chronic venous insufficien …
Daflon 500 mg and venous leg ulcer: new results from a meta-analysis.
Smith PC. Smith PC. Angiology. 2005 Sep-Oct;56 Suppl 1:S33-9. doi: 10.1177/00033197050560i106. Angiology. 2005. PMID: 16193225
The objective of this study was to assess the effect of oral treatment with Daflon 500 mg (micronized purified flavonoid fraction [MPFF]) on leg ulcer healing. This study was conducted as a meta-analysis of randomized prospective studies using Daflon 500 mg as an ad …
The objective of this study was to assess the effect of oral treatment with Daflon 500 mg (micronized purified flavonoid fraction [MP …
Clinical benefits of Daflon 500 mg in the most severe stages of chronic venous insufficiency.
Ramelet AA. Ramelet AA. Angiology. 2001 Aug;52 Suppl 1:S49-56. doi: 10.1177/0003319701052001S07. Angiology. 2001. PMID: 11510597 Review.
Micronized purified flavonoid fraction (MPFF, 450 mg diosmin plus 50 mg hesperidin-Daflon 500 mg) is a potent venotropic drug used in the treatment of venous insufficiency. ...In venous leg ulcer, Daflon 500 mg's clinical efficacy has been demonstrated in add …
Micronized purified flavonoid fraction (MPFF, 450 mg diosmin plus 50 mg hesperidin-Daflon 500 mg) is a potent venotropic drug …
From symptoms to leg edema: efficacy of Daflon 500 mg.
Nicolaides AN. Nicolaides AN. Angiology. 2003 Jul-Aug;54 Suppl 1:S33-44. doi: 10.1177/0003319703054001S05. Angiology. 2003. PMID: 12934755 Review.
Its efficacy in decreasing CVI edema and ankle swelling has been proven in rigorous studies that are reviewed in this paper. Daflon 500 mg, a well-established oral flavonoid that consists of 90% micronized diosmin and 10% flavonoids expressed as hesperidin, may be p …
Its efficacy in decreasing CVI edema and ankle swelling has been proven in rigorous studies that are reviewed in this paper. Daflon 5 …
Pharmacology of Diosmin, a Citrus Flavone Glycoside: An Updated Review.
Gerges SH, Wahdan SA, Elsherbiny DA, El-Demerdash E. Gerges SH, et al. Eur J Drug Metab Pharmacokinet. 2022 Jan;47(1):1-18. doi: 10.1007/s13318-021-00731-y. Epub 2021 Oct 23. Eur J Drug Metab Pharmacokinet. 2022. PMID: 34687440 Review.
Daflon is an oral phlebotonic flavonoid combination containing diosmin and hesperidin (9:1) that is commonly used for the management of blood vessel disorders. ...Accordingly, diosmin is a potential effective and safe treatment for many diseases. However, …
Daflon is an oral phlebotonic flavonoid combination containing diosmin and hesperidin (9:1) that is commonly used for the mana …
Daflon attenuates cisplatin-induced cerebellar neurotoxicity, anxiety-like behavior, and motor dysfunction by downregulating TLR4/NF-kB signaling.
Fidelis FB, Akhigbe TM, Oladipo AA, Oyedokun PA, Lasisi-Sholola AS, Adepoju OP, Ajao O, Adeleye OO, Ogundipe OO, Akhigbe RE. Fidelis FB, et al. BMC Pharmacol Toxicol. 2025 Nov 21;27(1):13. doi: 10.1186/s40360-025-01046-3. BMC Pharmacol Toxicol. 2025. PMID: 41272912 Free PMC article.
However, the effect of daflon on cisplatin-induced cerebellar neurotoxicity has not been documented. AIM: The present study evaluated the effect of daflon in cisplatin-induced cerebellar toxicity. ...MATERIALS AND METHODS: Twenty male Wistar rats were acclimatized f …
However, the effect of daflon on cisplatin-induced cerebellar neurotoxicity has not been documented. AIM: The present study evaluated …
Efficacy and Safety of Daflon in the Treatment of Idiopathic Epistaxis.
Attia TM. Attia TM. Am J Rhinol Allergy. 2019 Jan;33(1):62-68. doi: 10.1177/1945892418809237. Epub 2018 Nov 5. Am J Rhinol Allergy. 2019. PMID: 30394805 Clinical Trial.
OBJECTIVE: To assess the efficacy and safety of Daflon in the treatment of idiopathic epistaxis. METHODS: This is an open-label randomized clinical trial conducted on patients with idiopathic epistaxis comparing 1 group receiving Daflon for 1 month and a second gr …
OBJECTIVE: To assess the efficacy and safety of Daflon in the treatment of idiopathic epistaxis. METHODS: This is an open-label rand …
Micronized Purified Flavonoid Fraction in Hemorrhoid Disease: A Systematic Review and Meta-Analysis.
Sheikh P, Lohsiriwat V, Shelygin Y. Sheikh P, et al. Adv Ther. 2020 Jun;37(6):2792-2812. doi: 10.1007/s12325-020-01353-7. Epub 2020 May 12. Adv Ther. 2020. PMID: 32399811 Free PMC article.
Venoactive drugs, such as micronized purified flavonoid fraction (MPFF; Daflon( )), have been used to treat HD and their clinical benefits have been demonstrated in previous meta-analyses of clinical trials. ...
Venoactive drugs, such as micronized purified flavonoid fraction (MPFF; Daflon( )), have been used to treat HD and their clinical ben …
Cellular basis of inflammation, edema and the activity of Daflon 500 mg.
Friesenecker B, Tsai AG, Intaglietta M. Friesenecker B, et al. Int J Microcirc Clin Exp. 1995;15 Suppl 1:17-21. doi: 10.1159/000179090. Int J Microcirc Clin Exp. 1995. PMID: 8748884 Review.
This phenomenon can be observed using microvascular methods in which ischemia-reperfusion-induced inflammation-like condition are analyzed in terms of the increased adherence of leukocytes to the venular endothelium. Pretreatment with Daflon 500 mg, a purified, micronized, …
This phenomenon can be observed using microvascular methods in which ischemia-reperfusion-induced inflammation-like condition are analyzed i …
961 results